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Rural Appalachia Battling the Intersection of Two Crises: COVID-19 and 
Substance Use Disorders 
Abstract 
During the COVID-19 pandemic, rural Appalachia is at great risk of unforeseen side effects including 
increased mortality from substance use disorders (SUDs). People living with SUDs are at increased risk 
for both exposure to and poor outcomes from COVID infection. The economic impacts of COVID-19 must 
also be considered. As rural Appalachia combats the substance use crisis amidst the COVID-19 
pandemic, the geographic economic, health and social inequities within our region must be considered. 
As a national recovery is sought, we should reimagine federal policies that center the economic and 
public health of rural Appalachia addressing the two crises. 
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n the midst of the COVID-19 pandemic, rural Appalachia is at risk for 
previously unforeseen side effects from physical distancing needed to contain 
the virus, including increased mortality from substance-use disorders 
(SUDs). In 2015, drug overdose mortality rates in Appalachia were 65% higher 
than the national average, driven largely by opioid use. While rates had declined, 
drug overdose mortality rates in Appalachia remained 48% higher than the 
national average in 2018, the most recent year of data available.1 Since that time, 
early data from the Centers for Disease Control and Prevention (CDC) show rising 
drug overdose mortality rates nationally, and anecdotally, partners in 
Appalachia attribute those most recent trends to the impact of COVID-19. 
  
People living with SUDs are at increased risk for both exposure to and poor 
outcomes from COVID infection.2 They experience homelessness and 
incarceration at greater rates than the general population, making physical 
distancing difficult or impossible, placing individuals at increased risk for 
COVID-19 exposure and transmission.3 Other risks associated with SUDs 
include poverty, housing and food insecurity, lack of access to health care, and 
complex chronic conditions, all of which complicate proper screening and 
treatment for COVID-19.4 Further, chronic use of high-dose opioids restricts 
breathing, which can lead to chronic respiratory disease, increasing the risk for 
COVID-19 morbidity and mortality.2 Methamphetamine use also places 
individuals at higher risk due to blood vessel restriction, pulmonary vessel 
disease, and pulmonary hypertension.2 
  
Even as individuals are at higher risk of overdose and COVID-19 mortality due 
to SUD, access to treatment services have been disrupted, including the vitally 
important medication-assisted treatment (MAT) for opioid-use disorder (OUD). 
MAT includes methadone, buprenorphine, and naltrexone. These substances are 
generally dispensed in-person in the context of a biopsychosocial clinic visit. Due 
to physical distancing measures, the federal government has relaxed 
restrictions, allowing providers to dispense 14- or 28-day prescriptions to 
patients who are deemed stable.5 Although these relaxed restrictions allow many 
patients with OUD to stay safely sheltered-in-place, some patients are still 
required to report to methadone clinics daily, or buprenorphine clinics weekly, 
to obtain their prescription. This requirement puts high-risk patients at greater 
risk for COVID exposure and transmission or risk of relapse and overdose if they 
are not able to access MAT. The use of telehealth services for MAT has 
significantly increased, thereby allowing many patients to stay safely sheltered-
in-place while also continuing biopsychosocial treatment for addiction.6  
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Programs like Self-Management and Recovery Training (SMART Recovery), 
Alcoholics Anonymous (AA), Narcotics Anonymous (NA), and other faith-based 
programs are key for patients in recovery. Many of these programs have shifted 
to virtual programming throughout the COVID pandemic in order to promote 
community support for recovery. For example, the Kentucky Opioid Response 
Effort has compiled a list of virtual meetings for those in recovery.7 Such virtual 
programming may prove helpful for geographically isolated residents far beyond 
the COVID pandemic. Despite these new virtual opportunities, there is concern 
that some patients may have difficulty participating due to lack of access to 
reliable Internet or phone services.8 
  
Additionally, syringe-service programs (SSPs)—community-based programs that 
provide access to and disposal of sterile syringes and injection equipment, 
vaccination, testing for infectious diseases, and naloxone distribution—have 
been negatively affected throughout the pandemic.9 Although considered 
essential public health services by the CDC,9,10 one study found that 25% of 
SSPs have closed at least one site since the start of the pandemic.11 
  
The economic impacts of COVID-19 must also be considered. Based on data from 
the Great Recession, which strongly correlated unemployment with suicide and 
drug overdose deaths, the Well Being Trust and Robert Graham Center for Policy 
Studies in Family Medicine and Primary Care found that approximately 75,000 
Americans could die due to drug or alcohol misuse or suicide as a result of the 
COVID-19 pandemic.12 This poses a significant concern due to loss of work and 
local economic decline for rural Appalachian residents.  
 
As rural Appalachia combats the substance use crisis amidst the COVID-19 
pandemic, we must reflect on the geographic, economic, health, and social 
inequities within our region. It is vital that as we seek a national recovery that 
results in a stronger America, we reimagine federal policies that center the 
economic and public health of rural Appalachia.13 
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